Monzr M Al Malki

Trials

Studies that name Monzr M Al Malki as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:11 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT07582172 · Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

  City of Hope Medical Center · recruiting · Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome · principal investigator
• Ph2
  NCT06815003 · Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

  City of Hope Medical Center · recruiting · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia · principal investigator
• Ph1
  NCT06572631 · Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor

  City of Hope Medical Center · withdrawn · Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Syndrome, Refractory Acute Myeloid Leukemia · principal investigator
• Ph3
  NCT06169267 · Passive Music Intervention for the Reduction of Anxiety in Patients Undergoing Bone Marrow Aspiration and/or Biopsy

  City of Hope Medical Center · active not recruiting · Hematopoietic and Lymphoid System Neoplasm · principal investigator
• Ph1
  NCT05823480 · Magrolimab in Combination with Azacitidine After Allogeneic HCTin Treating Patients with High-Risk AML or MDS

  City of Hope Medical Center · withdrawn · Acute Myeloid Leukemia, Myelodysplastic Syndrome · principal investigator
• Ph1
  NCT05443425 · Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies

  City of Hope Medical Center · recruiting · Acute Graft Versus Host Disease, Hematopoietic and Lymphoid System Neoplasm · principal investigator
• Ph2
  NCT05364762 · Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants

  City of Hope Medical Center · active not recruiting · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia · principal investigator
• N/A
  NCT04666025 · SARS-CoV-2 Donor-Recipient Immunity Transfer

  City of Hope Medical Center · completed · Accelerated Phase CML, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia · principal investigator
• Ph2
  NCT04262843 · Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

  City of Hope Medical Center · active not recruiting · Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome · principal investigator
• Ph1
  NCT03118492 · Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

  City of Hope Medical Center · active not recruiting · Secondary Myelofibrosis · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 12:11 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.

NIH grants that fund their trials

These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.

• Leadership, Planning and Evaluation
  P30CA033572 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI JOHN D. CARPTEN · fiscal years 2004 to 2026
  Named on NCT07582172, NCT06815003, NCT06572631, NCT06169267, NCT05823480, NCT05443425, NCT05364762, NCT04666025, NCT03118492